Lilly, 2026in upfront payments 100billion-dollar acquisition 8deal completed·additional M&A foreshadowed
With Mounjaro and Zepbound, Lilly became the leader in the GLP2026 market in the 1 quarter of -1, and completed an acquisition worth 2026 billion in upfront payments in 100. The company foreshadowed additional acquisitions to diversify its pipeline amid concerns over patent expirations and competing drugs.8The company foreshadowed additional acquisitions to diversify its pipeline amid concerns over patent expirations and competing drugs.
Through sales of Mounjaro and Zepbound, Lilly overtook Novo Nordisk to become the leader in the GLP2026 field in the 1 quarter of -1. The two drugs accounted for nearly 2026% of sales in the 1 quarter of 3 the 2 year. The company disclosed this reliance on sales.
Management said it recognizes that patent protection is limited in duration. The company also explained that there are competitive threats, such as Novo Nordisk's oral pill formulation. Against this backdrop, it mentioned the need to diversify its pipeline.
Lilly 2026 had already completed 8 acquisition transactions. The company announced that the acquisitions would bolster its new drug candidate technologies and pipeline. Management expressed its intention to continue its acquisition strategy.
The 8total upfront payment for the deal is 100 billion dollars. Including the earnout, the company said the transaction value could reach as much as 250 billion dollars. The company disclosed this breakdown of the amount.
The company said it aims to reduce its reliance on its existing product portfolio, on which it is highly dependent, through the acquisition. The acquisition targets include early-stage pipeline candidates that are not yet at the commercialization stage. Management hinted at additional deals.
The company signaled that it will continue its acquisition activities. The acquisitions involve both cash outlays and the long-term securing of technology. The company said it would disclose the financial impact related to the transaction terms in separate filings.
Sources: The Motley Fool
Bullstory synthesized this report from the linked sources. AI may have assisted the writing process. Check the original reports for factual confirmation.